Cross-sectional analysis explores cerebral hypoperfusion and cognitive symptoms in long COVID patients, suggesting vascular dysfunction as a key factor.
Motivation: Many long COVID patients experience cognitive symptoms, potentially linked to reduced cerebral blood flow, which may result from microclots and other vascular or inflammatory mechanisms. Goal(s): To determine whether long COVID patients exhibit cerebral hypoperfusion patterns as measured by ASL. Approach: A cross-sectional design utilizing Arterial Spin Labeling (ASL) and structural images was employed in 125 Long COVID patients and 34 controls, analyzing CBF across 146 brain regions. Results: Significant reductions in CBF were found in frontal, temporal, and parietal regions as well several images with arterial transit artifacts (ATA). Impact: Our results indicate that cerebral hypoperfusion may serve as a biomarker to evaluate new treatments for long COVID, reinforcing the hypothesis that vascular dysfunction underlies its cognitive symptoms. This could improve diagnostic accuracy and guide targeted interventions.
No takes yet. Share an insight, caveat, or question.
Cataldo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: